HL
Hong Liu Shi
About Hong Liu Shi
Data last updated:
Hong Liu Shi is a Director at Abbvie Therapeutics India Private Limited (since 2024) and Director at Abbvie Healthcare India Private Limited (since 2024). The companies operate in Healthcare and Consumer Goods. The 2 current companies with reported revenue have a combined latest revenue of ₹711 Cr; the largest is Abbvie Therapeutics India Private Limited at ₹533 Cr (FY 2026).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Abbvie Therapeutics India Private Limited U33201KA1994PTC023162 | Director | 11 Jan 2024 | 1994 | ₹533 Cr (FY 2026) | Active |
| Abbvie Healthcare India Private Limited U85190KA2008PTC048318 | Director | 11 Jan 2024 | 2008 | ₹179 Cr (FY 2025) | Active |
Board colleagues of Hong Liu Shi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ajay Gopikisan Piramal | 00028116 | Abbvie Therapeutics India Private Limited | Director |
| Anup Arvind Godbole | 09342708 | Abbvie Therapeutics India Private Limited | Additional Director |
| Kesavan Gopinath | 10307250 | Abbvie Therapeutics India Private Limited | Director |
| Perumal Chinnaiah | Abbvie Therapeutics India Private Limited | Company Secretary | |
| Suresh Pattathil | 02748206 | Abbvie Therapeutics India Private Limited , Abbvie Healthcare India Private Limited | Managing Director |
| Swati Ajay Piramal | 00067125 | Abbvie Therapeutics India Private Limited | Director |
| Vidhan Kedia | 06718606 | Abbvie Therapeutics India Private Limited , Abbvie Healthcare India Private Limited | Director |
| Vivek Valsaraj | 06970246 | Abbvie Therapeutics India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hong Liu Shi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hong Liu Shi
Hong Liu Shi currently holds 2 directorships: Abbvie Therapeutics India Private Limited (Director, since 11 Jan 2024, revenue ₹533 Cr (FY 2026)); Abbvie Healthcare India Private Limited (Director, since 11 Jan 2024, revenue ₹179 Cr (FY 2025)).
Hong Liu Shi was first appointed on 11 Jan 2024 as Director at Abbvie Therapeutics India Private Limited.
The 2 current companies of Hong Liu Shi that report revenue have a combined latest revenue of ₹711 Cr: Abbvie Therapeutics India Private Limited ₹533 Cr (FY 2026); Abbvie Healthcare India Private Limited ₹179 Cr (FY 2025).
The current boards of Hong Liu Shi's companies include Ajay Gopikisan Piramal (Abbvie Therapeutics India Private Limited), Anup Arvind Godbole (Abbvie Therapeutics India Private Limited), Kesavan Gopinath (Abbvie Therapeutics India Private Limited), Perumal Chinnaiah (Abbvie Therapeutics India Private Limited), Suresh Pattathil (Abbvie Therapeutics India Private Limited), Swati Ajay Piramal (Abbvie Therapeutics India Private Limited), among others.